AI-RPE
Live / Applied — Second extension granted (statement of use) (as of 29 Sept 2025)
What this means for you
Not registered yet, but its 20 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98278305
- Mark type
- Stylized text
- Filed
- 20 Nov 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Nathan T. Harris
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations comprising cells for application in the respiratory system for the treatment of disease
Owner
- Sentinel BioTherapeutics Inc., Newtown, PA, US
- Sentinel BioTherapeutics Inc., Newtown, PA, US
Prosecution history
- 30 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2025 — SOU EXTENSION 2 GRANTED
- 29 Sept 2025 — SOU EXTENSION 2 FILED
- 29 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2025 — SOU EXTENSION 1 GRANTED
- 02 Apr 2025 — SOU EXTENSION 1 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2024 — ASSIGNED TO EXAMINER
- 03 Jan 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED